Results 1 to 10 of about 68,228 (254)
Treatment effectiveness of antibiotic therapy in Veterans with multidrug-resistant Acinetobacter spp. bacteremia [PDF]
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Objective: To describe antimicrobial therapy used for multidrug-resistant (MDR) Acinetobacter spp. bacteremia in Veterans and impacts on mortality. Methods: This was a retrospective cohort study of hospitalized Veterans Affairs patients from 2012 to ...
Amanda Vivo +6 more
doaj +2 more sources
Molecular epidemiology of quinolone resistance in Acinetobacter spp. [PDF]
Clinical Microbiology and Infection, 1998 OBJECTIVE: To determine whether similar mutations to quinolone resistance in the gyrA subunit of DNA gyrase and the parC subunit of topoisomerase IV are occurring independently in genotypically unrelated clinical isolates of Acinetobacter spp., or whether worldwide clonal spread of particular resistant strains is occurring.
Rebecca J. Seward, K. J. Towner
openalex +4 more sources
Genome-wide identification and oxacillinase OXA distribution characteristics of Acinetobacter spp. based on a global database [PDF]
Frontiers in Microbiology, 2023 ObjectiveTo use genomic analysis to identify Acinetobacter spp. and to explore the distribution characteristics of ß-lactamase oxallicinases (blaOXA) among Acinetobacter species globally.MethodsGenomes of global Acinetobacter spp.
Jia Li +8 more
doaj +2 more sources
Acinetobacterspp. in Gunshot Injuries [PDF]
Emerging Infectious Diseases, 2008 To the Editor: Challenges posed by Acinetobacter spp. result from multidrug resistance, nosocomial spread, and hospital-wide outbreaks (1–3). We evaluated Acinetobacter spp. infections from gunshot injuries received during the April 2006 East Timor conflict (for a description of these events and further reading, see http://en.wikipedia.org/wiki ...
James Elston +3 more
openalex +5 more sources
Epidemiology of nosocomial colonization/infection caused by Acinetobacter spp. in patients of six surgical clinics in war and peacetime [PDF]
Vojnosanitetski Pregled, 2011 Background/Aim. Acinetobacter spp. has emerged as nosocomial pathogen during the past few decades in hospitals all over the world, but it has increasingly been implicated as a serious nosocomial pathogen in military hospitals.
Šuljagić Vesna +11 more
doaj +2 more sources
Comment on: Acinetobacter spp. and time-kill studies [PDF]
Journal of Antimicrobial Chemotherapy, 2007 Sir, We are in agreement with Dr Lopardo on various issues that affect antibiotic synergy testing, and in particular, on some of the intrinsic limitations of time–kill methodology. We also agree that the MIC is not a static parameter, and that one of the limitations of our study (as mentioned in the Discussion section) was that we were unable to ...
Joon Young Song, Hee Jin Cheong
+7 more sources
Acinetobacter spp. in neonatal sepsis: an urgent global threat [PDF]
Frontiers in AntibioticsNeonatal sepsis causes substantial morbidity and mortality, the burden of which is carried by low-income countries (LICs). The emergence of multidrug-resistant pathogens in vulnerable neonatal populations poses an urgent threat to infant survival ...
Kamla Pillay +5 more
doaj +2 more sources
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations [PDF]
Microbiology SpectrumCarbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major threats and have few approved therapeutic options. Non-fermenting Gram-negative isolates were collected from hospitalized inpatients from 49 sites in 6 European countries
Anne Santerre Henriksen +7 more
doaj +2 more sources
Antimicrobial resistance of Acinetobacter spp. in Europe [PDF]
Clinical Microbiology and Infection, 2004 Bacteria of the genus Acinetobacter are ubiquitous in nature. These organisms were invariably susceptible to many antibiotics in the 1970s. Since that time, acinetobacters have emerged as multiresistant opportunistic nosocomial pathogens. The taxonomy of the genus Acinetobacter underwent extensive revision in the mid-1980s, and at least 32 named and ...
van Looveren, Marleen, Goossens, Herman
openaire +7 more sources
Pathogens, 2021 Acinetobacter spp., the nosocomial pathogen, forms strong biofilms and is resistant to numerous antibiotics, causing persistent infections. This study investigates the antibacterial and anti-biofilm activity of polymyxin E alone and in combination with ...
Munaf AL-Dulaimi +6 more
doaj +1 more source